ORIC Pharmaceuticals Inc (NASDAQ: ORIC) is 46.85% higher on its value in year-to-date trading and has touched a low of $3.90 and a high of $14.67 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The ORIC stock was last observed hovering at around $10.23 in the last trading session, with the day’s loss setting it -9.04%.
Currently trading at $1.19M, the stock is 12.26% and 51.55% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.89 million and changing 889656% at the moment leaves the stock 25.59% off its SMA200. ORIC registered 30.11% gain for a year compared to 6-month loss of 27.89%. The firm has a 50-day simple moving average (SMA 50) of $6.9286 and a 200-day simple moving average (SMA200) of $8.360525.
The stock witnessed a 81.66% gain in the last 1 month and extending the period to 3 months gives it a 79.49%, and is 13.88% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.95% over the week and 9.14% over the month.
ORIC Pharmaceuticals Inc (ORIC) has around 115 employees, a market worth around $894.85M and $0.00M in sales. Distance from 52-week low is 169.57% and -28.43% from its 52-week high. The company has generated returns on investments over the last 12 months (-60.46%).
The EPS is expected to grow by 3.91% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
198.0 institutions hold shares in ORIC Pharmaceuticals Inc (ORIC), with institutional investors hold 111.54% of the company’s shares. The shares outstanding are 71.08M, and float is at 47.89M with Short Float at 26.54%. Institutions hold 102.70% of the Float.
The top institutional shareholder in the company is NEXTECH INVEST LTD. with over 5.29 million shares valued at $37.37 million. The investor’s holdings represent 7.5136 of the ORIC Shares outstanding. As of 2024-06-30, the second largest holder is FMR LLC with 4.92 million shares valued at $34.79 million to account for 6.9943 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 4.83 million shares representing 6.8671 and valued at over $34.15 million, while VR ADVISER, LLC holds 6.2468 of the shares totaling 4.39 million with a market value of $31.07 million.
ORIC Pharmaceuticals Inc (ORIC) Insider Activity
The most recent transaction is an insider sale by Piscitelli Dominic, the company’s Chief Financial Officer. SEC filings show that Piscitelli Dominic sold 32,466 shares of the company’s common stock on Jun 24 ’25 at a price of $10.50 per share for a total of $0.34 million. Following the sale, the insider now owns 68317.0 shares.
ORIC Pharmaceuticals Inc disclosed in a document filed with the SEC on Jun 23 ’25 that Piscitelli Dominic (Chief Financial Officer) sold a total of 1,034 shares of the company’s common stock. The trade occurred on Jun 23 ’25 and was made at $10.00 per share for $10344.0. Following the transaction, the insider now directly holds 0.1 million shares of the ORIC stock.
Still, SEC filings show that on Jun 20 ’25, You Angie (Director) acquired 26,597 shares at an average price of $9.39 for $0.25 million. The insider now directly holds 26,597 shares of ORIC Pharmaceuticals Inc (ORIC).
